Cubist Systematic Strategies, LLC Wave Life Sciences Ltd. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 163,196 shares of WVE stock, worth $2.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

163,196

Holding current value

$2.33 Million

% of portfolio

0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.12 - $9.01 $835,563 - $1.47 Million	163,196 New	163,196 $1.34 Million
Q1 2024 May 15, 2024	BUY	$3.54 - $6.84 $241,739 - $467,089	68,288 Added 27315.2%	68,538 $422,000
Q4 2023 Feb 14, 2024	BUY	$4.16 - $6.87 $1,040 - $1,717	250 New	250 $1,000
Q1 2023 May 15, 2023	SELL	$3.58 - $6.3 $109,777 - $193,183	-30,664 Reduced 30.02%	71,489 $309,000
Q4 2022 Feb 14, 2023	BUY	$3.18 - $7.0 $305,066 - $671,531	95,933 Added 1542.33%	102,153 $715,000
Q3 2022 Nov 14, 2022	SELL	$2.37 - $4.28 $33,763 - $60,972	-14,246 Reduced 69.61%	6,220 $22,000
Q2 2022 Aug 15, 2022	BUY	$1.23 - $3.25 $25,173 - $66,514	20,466 New	20,466 $67,000
Q1 2022 May 16, 2022	SELL	$2.0 - $3.28 $22,528 - $36,945	-11,264 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.14 - $5.15 $17,703 - $29,035	-5,638 Reduced 33.36%	11,264 $35,000
Q3 2021 Nov 15, 2021	BUY	$4.89 - $7.12 $16,391 - $23,866	3,352 Added 24.74%	16,902 $83,000
Q2 2021 Aug 16, 2021	SELL	$5.65 - $7.47 $349,548 - $462,146	-61,867 Reduced 82.03%	13,550 $90,000
Q1 2021 May 17, 2021	BUY	$5.61 - $12.01 $285,605 - $611,429	50,910 Added 207.74%	75,417 $423,000
Q4 2020 Feb 16, 2021	SELL	$6.99 - $9.26 $68,341 - $90,535	-9,777 Reduced 28.52%	24,507 $193,000
Q3 2020 Nov 16, 2020	BUY	$8.49 - $19.54 $141,256 - $325,106	16,638 Added 94.29%	34,284 $291,000
Q2 2020 Aug 14, 2020	BUY	$7.44 - $11.29 $131,286 - $199,223	17,646 New	17,646 $184,000
Q1 2020 May 15, 2020	SELL	$6.94 - $14.22 $51,508 - $105,540	-7,422 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.99 - $37.6 $40,125 - $188,827	5,022 Added 209.25%	7,422 $59,000
Q3 2019 Nov 14, 2019	BUY	$19.17 - $27.4 $11,502 - $16,440	600 Added 33.33%	2,400 $49,000
Q2 2019 Aug 14, 2019	SELL	$22.93 - $42.84 $446,607 - $834,394	-19,477 Reduced 91.54%	1,800 $47,000
Q1 2019 May 15, 2019	BUY	$32.69 - $47.91 $691,556 - $1.01 Million	21,155 Added 17340.16%	21,277 $827,000
Q4 2018 Feb 14, 2019	SELL	$37.1 - $50.11 $27,787 - $37,532	-749 Reduced 85.99%	122 $5,000
Q3 2018 Nov 14, 2018	BUY	$36.35 - $55.2 $31,660 - $48,079	871 New	871 $44,000
Q1 2018 May 15, 2018	SELL	$32.45 - $54.7 $6,490 - $10,940	-200 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$21.8 - $39.35 $4,360 - $7,870	200	200 $7,000

Others Institutions Holding WVE

# of Institutions

164

Shares Held

117M

Call Options Held

148K

Put Options Held

109K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.24B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Wave Life Sciences Ltd. Transaction History